Rethinking the pathogenesis of asthma - Keystone Symposium. 8-13 February 2002, Santa Fe, NM, USA.
This Keystone meeting entitled 'Rethinking the Pathogenesis of Asthma' was held at Santa Fe, USA. Numerous topics were discussed, including the pathogenesis of asthma, from the perspective of better understanding the contribution of the immune system and the impact of environmental factors on the development of allergic diseases, and current research and new trends in immunotherapy to prevent and treat asthma. Of particular relevance to novel drug development was a session entitled 'Novel therapeutic approaches' co-chaired by Achsah D Keegan (American Red Cross, USA) and Arthur M Krieg (Coley Pharmaceutical Group, USA), in which the results of several clinical trial studies on potential new asthma therapies were presented.
Zuany-Amorim
Claudia
C
Novartis Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, UK. claudia.zuany-amorim_fromond@pharma.novartis.com